KALA BIO, Inc. SEC filings KALA
KALA BIO, Inc. has 675 filings in SEC EDGAR's recent list, going back to Dec 23, 2009. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 22, 2026 | — |
| S-3/A | Filing | Jun 12, 2026 | — |
| S-3 | Shelf registration | May 7, 2026 | — |
| 424B3 | Prospectus | Feb 17, 2026 | — |
| S-3 | Shelf registration | Feb 10, 2026 | — |
| 424B5 | Prospectus supplement | Jan 8, 2026 | — |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| 424B3 | Prospectus | Feb 4, 2025 | — |
| S-3 | Shelf registration | Jan 24, 2025 | — |
| S-8 | Employee stock plan registration | Jan 3, 2025 | — |
| 424B5 | Prospectus supplement | Sep 6, 2024 | — |
| 424B3 | Prospectus | Jul 31, 2024 | — |
| S-3 | Shelf registration | Jul 25, 2024 | — |
| 424B5 | Prospectus supplement | Mar 29, 2024 | — |
| S-8 | Employee stock plan registration | Mar 29, 2024 | — |
| S-8 | Employee stock plan registration | Jun 22, 2023 | — |
| S-3/A | Filing | May 9, 2023 | — |
| 424B3 | Prospectus | Mar 14, 2023 | — |
| S-3 | Shelf registration | Mar 3, 2023 | — |
| S-3 | Shelf registration | Mar 3, 2023 | — |
| 424B5 | Prospectus supplement | Jan 19, 2023 | — |
| S-8 | Employee stock plan registration | Jan 4, 2023 | — |
| S-8 | Employee stock plan registration | Mar 29, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| S-8 | Employee stock plan registration | Jun 25, 2020 | — |
| S-3 | Shelf registration | May 7, 2020 | — |
| 424B5 | Prospectus supplement | Mar 12, 2020 | — |
| 424B5 | Prospectus supplement | Mar 11, 2020 | — |
| S-8 | Employee stock plan registration | Feb 13, 2020 | — |
| S-8 | Employee stock plan registration | Mar 12, 2019 | — |
| 424B2 | Prospectus | Oct 3, 2018 | — |
| 424B2 | Prospectus | Oct 2, 2018 | — |
| S-3/A | Filing | Aug 20, 2018 | — |
| S-3 | Shelf registration | Aug 9, 2018 | — |
| S-8 | Employee stock plan registration | Apr 2, 2018 | — |
| S-8 | Employee stock plan registration | Jul 21, 2017 | — |
| 424B4 | Prospectus | Jul 20, 2017 | — |
| S-1/A | Amended registration statement | Jul 10, 2017 | — |
| S-1 | Registration statement | Jun 23, 2017 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KALA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Arlington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1479419
- Former names
- KALA BIO, Inc. (until Nov 3, 2026); Kala Pharmaceuticals, Inc. (until Jun 23, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.